Greg N. Brooke
Colchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
MSC-delivered high-affinity variants of soluble PD1 lead to tumor regression.
Journal: Cytotherapy
Published: January 11, 2026
The role of Notch signalling and its crosstalk with oestrogen receptor signalling in breast cancer.
Journal: Cancer metastasis reviews
Published: November 11, 2025
Analysis of coding gene expression from small RNA sequencing.
Journal: Genome research
Published: September 04, 2025
Reliable repurposing of the antibody interactome inside the cell.
Journal: Nature communications
Published: July 16, 2025
Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer.
Journal: Oncogene
Published: May 07, 2025
Thieno[2,3-b]pyridine compounds potently inhibit prostate cancer growth and motility.
Journal: Endocrine oncology (Bristol, England)
Published: December 16, 2024
Author Correction: PSIP1/LEDGF reduces R-loops at transcription sites to maintain genome integrity.
Journal: Nature communications
Published: June 07, 2024
Nucleosome reorganisation in breast cancer tissues.
Journal: Clinical epigenetics
Published: December 29, 2023
The antiviral potential of the antiandrogen enzalutamide and the viral-androgen signaling interplay in seasonal coronaviruses.
Journal: Journal of medical virology
Published: December 06, 2023
PSIP1/LEDGF reduces R-loops at transcription sites to maintain genome integrity.
Journal: Nature communications
Published: February 23, 2023
Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients.
Journal: Viruses
Published: October 31, 2022
Last Updated: 09/26/2026